An Early Breakfast May Reduce the Risk of Developing type 2 Diabetes

by ISGlobal - Instituto de Salud Global de Barcelona

Results suggest that a first meal before 8 am and a last meal before 7 pm may help reduce the incidence of type 2 diabetes

Read more

Researchers find a molecular mechanism involved in type 2 diabetes

by Universitat de Barcelona

The stud has described a decrease in mitochondrial proteins that synthesize complex subunits of the respiratory chain. This decrease in proteins is associated with an increase in intracellular nitric ...

Read more

CDF15 cytokine, a promising therapeutic target against type 2 diabetes

by Universitat de Barcelona

A team led by Professor Manuel Vázquez-Carrera, from the Faculty of Pharmacy and Food Sciences and the Institute of Biomedicine (IBUB) of the UB, has conducted a review study on the Growth Differenti...

Read more

The UJI proves the positive effects of a plant hormone to reverse brain damage caused by obesity

by Universitat Jaume I

A research led by lecturer Ana María Sánchez from the Faculty of Health Sciences has analysed how to counteract neuroinflammation caused by high-fat diets and type 2 diabetes

Read more

An increase in low density lipoproteins would favour insulin resistance, a disease occurring in Type 2 Diabetes

by Universitat de Barcelona

A study led by the University of Barcelona proved that low-density proteins (VLDL) can worsen insulin resistance, a disease that favours the development of type 2 diabetes. According to the researcher...

Read more

New potential treatment for diabetes, with the participation of Mind the Byte

by Mind the Byte

Type 2 diabetes (T2D) is a complex disease caused by the interaction of genetic and environmental factors. It happens when pancreatic islets fail to produce enough insulin, or body target cells do not...

Read more

Scientists identify a therapeutic target for type 2 diabetes treatments

by Universitat de Barcelona

Researchers of the University of Barcelona (UB) described a new therapeutic target, the elF2a Kinase, for the treatment of type 2 diabetes and other metabolic diseases. The work was focused on the stu...

Read more

New type 2 diabetes biomarker identified

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

The study has shown that the TXNIP gene is associated to patients with poor control of their glucose levels

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream